Gadolinium-160: The Essential Precursor for Terbium-161 Production in Targeted Cancer Radiotherapy

Gadolinium-160: The Essential Precursor for Terbium-161 Production in Targeted Cancer Radiotherapy BY Tao, Published Dec 28, 2025   Terbium-161 (Tb-161) is emerging as one of the most promising “next-step” therapeutic radionuclides for targeted radionuclide therapy (also called targeted radiotherapy or radioligand therapy) because it behaves chemically like the widely used Lutetium-177 (Lu-177), yet delivers additional ultra-short-range electron dose that…